Donoghue Forlines LLC United Therapeutics Corp Transaction History

Donoghue Forlines LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $1.29 Million - $1.5 Million	4,134 New	4,134 $1.48 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $601,092 - $718,128	-3,342 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $19,092 - $23,736	-112 Reduced 3.24%	3,342 $600,000
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $79,894 - $90,747	-519 Reduced 13.06%	3,454 $578,000
Q4 2020 Feb 09, 2021	BUY	$101.87 - $151.79 $404,729 - $603,061	3,973 New	3,973 $603,000

676

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.